Abiopharma

🔍 ROBINS HARLAN S (Executive)

Company: Adaptive Biotechnologies Corp (ADPT)

Report Date: 2026-03-11

Detailed Transactions and Holdings:

• Sold 140,666 shares of Common Stock at $13.17 per share (Direct)
  Date: 2026-03-11 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,851,658.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 329,600 shares of Common Stock at $13.17 per share (Direct)
  Date: 2026-03-11 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,522,058.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by Issuer's election under the equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
• F2: This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance share units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.